- Country: USA
- Summary: Request For Information (RFI) (2) for device & maintenance services for medical point-of-care molecular disease analyzer
- UST Ref No: 119304985
- Deadline: 28 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 70Z02325_11100002_RFI(2)
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Title: Request for Information (RFI-2) for Device and Maintenance Services for Medical Point-of-Care Molecular Disease Analyzer
Agency: United States Coast Guard (USCG)
Date of Issuance: 16 May 2025
Response Due Date: 28 May 2025
Point of Contact:
Jamison Harned
Contracting Officer
Jamison.W.Harned@uscg.mil
RFI Identifier Number: 70Z02325_11100002_RFI-ONLY
NAICS Code: 621511 - Medical Laboratories
Product Service Code: H265 - Equipment and Materials Testing - Medical, Dental, and Veterinary Equipment and Supplies
Introduction/Purpose
The United States Coast Guard (USCG) is issuing this Request For Information (RFI) to better understand the current marketplace, solicit additional information, and explore possible alternative solutions for an upcoming requirement. This is NOT a solicitation and is only intended as an RFI.
The USCG Health, Safety, and Work-Life Service Center (HSWL-SC) seeks sources that can provide Point-of-Care molecular disease analyzers for USCG ashore units. Currently, the USCG owns seventy-two (72) Cepheid GeneXpert systems, consisting of both two (2) and four (4) bay variants, with fifty-two (52) units operating under an active service plan that runs through 29 September 2025.
We are looking to procure alternatives or replacements for our current Cepheid devices that are reaching their end of lifecycle. Recommendations will include both replacement devices and their corresponding device maintenance.
Background
Historically, the USCG has met its requirement by procuring Cepheid GeneXpert systems, fielding them throughout the USCG, and conducting a range of tests at the point-of-care. Contracts for maintenance service support were issued as sole-source awards, most recently under 70Z02324P11100002. The devices obtained were Cepheid GeneXpert Xpress GXIV-4-CLIA IV.
Current Status
The USCG currently owns 72 point-... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRequest For Information (RFI) (2) for device & maintenance services for medical point-of-care molecular disease analyzer - USA Tender
The HOMELAND SECURITY, DEPARTMENT OF | US COAST GUARD, a Government sector organization in USA, has announced a new tender for Request For Information (RFI) (2) for device & maintenance services for medical point-of-care molecular disease analyzer. This tender is published on USARFP under UST Ref No: 119304985 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-28.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
